Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Effects on Sensorimotor Gating in Schizophrenia
NCT03860597Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Apr 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Memantine First with Placebo First (2 arms). Primary endpoints: Prepulse Inhibition at 14 days, Mismatch Negativity at 14 days and 1 more. Started Apr 2018; status: completed.
02
Drugs
memantine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT03860597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03860597.